GROFF NORTH AMERICA

A Bold Vision for
Botanical Medicinalization
to Improve Human Health.

Groff North America is a biotechnology company focused on botanical medicinalization. We discover, isolate, stabilize genetics, and manufacture pharmaceutical-grade therapeutics from botanical sources.

DEA

Licensed Facilities

World-Class

Scientific Advisory Board

AI-First

Discovery Engine

Global

Import / Export

Core Capabilities

Pharmaceutical Consistency

We apply rigorous engineering principles to biological systems. By combining advanced genomics with federally compliant manufacturing, we can deliver the batch-to-batch consistency that the pharmaceutical industry demands.

Genomic Precision

In partnership with leading third-party services, our molecular breeding program utilizes a proprietary genomic probe to identify, isolate, and stabilize specific genetic markers responsible for targeted therapeutic production.

Explore Platform

Accelerated Pipeline

We identify novel botanical compounds in nature and collaborate with academic researchers to determine their mechanisms of action. By leveraging in silico validation and AI-driven discovery, we rapidly analyze configurations and binding affinities to accelerate our development timelines.

View Pipeline

Federal Compliance

Operating under 6 Schedule I DEA registrations, our facilities and protocols meet stringent federal requirements for the research, manufacturing, and export of controlled substances.

Investor Info

"Nature is the world's greatest pharmacy. Our mission is to unlock the therapeutic potential of complex botanicals—from fungi to flora—and deliver them with pharmaceutical precision."

T.J. Leverte